Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns
The issue, first reported in September, was linked to five patient injuries. Devices not being actively used should be returned to Johnson & Johnson MedTech for updates.
Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
How clinicians can combat health disparities in cardio-oncology
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Most adults know nothing about CKM syndrome—but it impacts nearly everyone
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

CDC vaccine committee issues new guidance for COVID-19 shots

The Advisory Committee on Immunization Practices recommended that all Americans six months and older consult a clinician before deciding to get a COVID vaccine, ending the pandemic-era policy that broadly encouraged getting the inoculation.

Oral semaglutide linked to significant weight loss as Novo Nordisk awaits FDA approval

An oral version of the popular GLP-1 drug was associated with multiple benefits, including considerable improvements in BMI and waist circumference. Previous research found that it reduces certain heart risks in patients with type 2 diabetes.

Stroke risk much higher for TAVR patients with carotid artery stenosis

Screening TAVR patients for CAS may provide significant value, according to a new meta-analysis of 15 different studies.

Hundreds of radiation therapy systems subject to FDA recall

A Class 2 recall has been issued for the systems due to a software glitch that could impact treatment accuracy.

artificial intelligence AI predictive analytics

Top US heart hospital launches new AI research lab

Mount Sinai Fuster Heart Hospital aims to take its use of AI during interventional procedures to the next level and find new ways to transform patient care.

baby parent parental leave family infant

New study suggests link between birth defects and preconception CT imaging

The findings raise concerns about women who are planning on becoming pregnant and imaging-related radiation exposure in the weeks leading up to conception.

Robin the Robot from Expper Technologies

Robin the Robot serves up smiles at nursing homes, children’s hospitals

The AI-powered device is helping alleviate staff shortages by making rounds and checking on patients.

Abbott has recalled its TactiFlex Ablation Catheter, Sensor Enabled, because of reports that the tip can separate.

Abbott warns EP labs the tip can detach from its TactiFlex ablation catheters

Improper removal of the catheter from the packaging can result in tip damage. Most damaged tips were detected prior to being used, but three tips did separate inside patients.

Clinical

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

How clinicians can combat health disparities in cardio-oncology

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes